MADDE KULLANIM BOZUKLUKLARINDA GENETİK: BİR GÖZDEN GEÇİRME

Ögel K, Uguz Ş, Sır A, ve ark. Türkiye’de ilköğretim ve ortaöğretim gençliği arasında esrar kullanım yaygınlığı. Bağımlılık Dergisi 2003; 4: 15–19.

Yüncü Z, Aydın C; Çoşkunol H, Altıntoprak E, Bayram AT. Çocuk ve ergenlere yönelik bir bağımlılık merkezinin 2 yıllık poliklinik kayıtlarının değerlendirilmesi Bağımlılık Dergisi 2006;7:31–37.

Merikangas K, Kupfer D J, Mood disorders:genetic aspects in, Comprehensive Textbook of Psychiatry Sixth Edition. Harold I.Kaplan, Benjamin J. Sadock (Eds).Volum: 1:1104–1115 Williams& Wilkins 1995 Maryland USA.

Gilligan SB, Reich T, Cloninger CR. Etiologic heterogeneity in alcoholism. Genet Epidemiol. 1987; 4:395–414.

Aston CE, Hill SY. Segregation analysis of alcoholism in families ascertained through a pair of male alcoholics. Am J Hum Genet. 1990; 46:879887.

Akarsu. N. Genetik hastalılara neden olan genlerin saptanmasında aile ağacı analizlerinin önemi. Hacettepe Tıp Dergisi 1999; 30: 1: 85–91.

Gunzerath L, Goldman d. G X E: a NIAAA workshop on gene-environment interactions. Alcohol Clin Exp Res 2003; 27:540–562.

Rutter M. The interplay of nature,nurture, ana developmental influences. The challenge ahead for mental health. Arch Gen Psychiatry 2002; 59:9961000.

Neiswanger K, Hill SY, Kaplan BB. Association and linkage studies of the TAQI A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Genet. 1995; 14;60:267–271.

Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D, Knowler WC, Lu RB, Bonne-Tamir B. DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. Alcohol Clin Exp Res. 1996; 20:697–705.

Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Wood R, Finley O, Sadlack F. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol. 1993; 10:59–67

Heath AC, Martin NG, Lynskey MT, Todorov AA, Madden PA. Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data.Twin Res. 2002; 5:113–124

Choi IG, Kee BS, Son HG, Ham BJ, Yang BH, Kim SH, Lee JS, Son BK, Lee BY, Lee SY, Chai YG, Shin HD. Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur Neuropsychopharmacol. 2006; 16:123–128.

Cadoret RJ, O’Gorman TW, Troughton E, Heywood E. Alcoholism and antisocial personality. Interrelationships, genetic and environmental factors. Arch Gen Psychiatry. 1985; 42:161–167.

Enoch MA, Goldman D. The genetics of alcoholism and alcohol abuse.Curr Psychiatry Rep. 2001; 3:144–151.

Lin SW, Anthenelli RM. Genetics factors in the risk for substance use disorders. Lowinson JH, Ruiz P, Milmann RB, Langrod JG (editors). Substance Abuse. A comprehensive textbook. Fourth Edition. Lippincott Williams & Willkins Philadelphia 2005; 33–48.

Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ. A population-based twin study of alcoholism in women. JAMA. 1992; 14;268:1877–1882.

Cloninger CR, Bohman M, Sigvardsson S. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men.Arch Gen Psychiatry. 1981; 38:861–868.

Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men.Psychol Med. 1997; 27:1381– 1396.

Rounsaville BJ, Kosten TR, Weissman MM, Prusoff B, Pauls D, Anton SF, Merikangas K. Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry. 1991; 48:33–42.

Hill SY, Locke J, Zezza N, Kaplan B, Neiswanger K, Steinhauer SR, Wipprecht G, Xu J. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry. 1998; 43:40–51.

Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80:105–116.

Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger JI Jr, Porjesz B, Schuc-kit MA, Reich T. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism Arch Gen Psychiatry. 1998 Nov;55:982-8. Erratum in: Arch Gen Psychiatry 2002; 59:153.

Cadoret RJ, Cain CA, Grove WM..Development of alcoholism in adoptees raised apart from alcoholic biologic relatives. Arch Gen Psychiatry. 1980; 37:561–563.

Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Clayton PJ. Heterogeneity in the inheritance of alcoholism. A study of male and female twins. Arch Gen Psychiatry. 1991; 48:19–28.

Hughes JR. Genetics of smoking: a brief review. Behav Ther 1986;17:335–344.

Kendler KS, Gardner CO Jr. Twin studies of adult psychiatric and substance dependence disorders: are they biased by differences in the environmental experiences of monozygotic and dizygotic twins in childhood and adolescence?Psychol Med. 1998; 28:625–633.

Hall W, Madden P, Lynskey M. The genetics of tobacco use: methods, findings and policy implications. Tob Control. 2002;11:119-124.

Kendler KS, Thornton LM, Pedersen NL. Tobacco consumption in Swedish twins reared apart and reared together.Arch Gen Psychiatry. 2000; 57:886–892.

Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology (Berl). 1995; 117: 2-10.

Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses. 1994; 42:257–260.

Comings DE, Ferry L, Bradshaw-Robinson S, Bur-chette R, Chiu C, Muhleman The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 1996; 6:73–79.

Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998; 4;90:358-363.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999; 18:14–20

Eichhammer P, Langguth B, Wiegand R, Kharraz A, Frick U, Hajak G. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).Psychopharmacology (Berl). 2003; 166:294–297.

Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Lin YL, Yanagi H, Tsuchiya S, Kawata K, Hamaguchi H, Arinami T. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev. 1999; 8:831–833.

Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev. 1998; 7:253–255.

Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol Psychiatry. 2000; 5:189-192.

Lee AM, Tyndale RF. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment. J Psychopharma-col. 2006; 20(4 Suppl):7-14.

Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G. Structure and function of neuronal nicotinic acetylcholine receptors.Prog Brain Res. 1996; 109:125-137.

Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, Boulter J. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci U S A. 2001; 13;98:3501– 3506.

Town T, Abdullah L, Crawford F, Schinka J, Ordo-rica PI, Francis E, Hughes P, Duara R, Mullan M. Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet. 1999; 88:458–461.

Szeto CY, Tang NL, Lee DT, Stadlin A. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport. 2001; 8;12:1103–1106.

Tyndale RF, Droll KP, Sellers EM. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence.Pharmacogenetics. 1997; 7:375-379.

Kranzler HR, Gelernter J, O’Malley S, Hernandez-Avila CA, Kaufman D. Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). Alcohol Clin Exp Res. 1998; 22:1359–1362.

Kendler KS, Neale MC, Thornton LM, Aggen SH, Gilman SE, Kessler RC. Cannabis use in the last year in a US national sample of twin and sibling pairs.Psychol Med. 2002; 32:551–554.

Luthar SS, Merikangas KR, Rounsaville BJ. Parental psychopathology and disorders in offspring. A study of relatives of drug abusers. J Nerv Ment Dis. 1993; 181:351–357.

Kendler KS, Prescott CA. Cocaine use, abuse and dependence in a population-based sample of female twins.Br J Psychiatry. 1998; 173:345–350.

Comings DE, Gonzalez N, Wu S, Saucier G, Johnson P, Verde R, MacMurray JP. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol Psychiatry. 1999; 4:484–487.